WM-130

N/A

Report date: 2023/01/14 18:58:06
NME

Base Information

Drug NameWM-130
Drug Alias NameWM-130
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMatrix metalloproteinase inhibitors
TargetsMatrix metalloproteinase
Therapy Area/IndicationsLiver Cirrhosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSecond Military Medical University Of Chinese People'S Liberation Army
China Registration ClassN/A

Develop Information

Active CompaniesSecond Military Medical University Of Chinese People'S Liberation Army
Inactive CompaniesN/A
Active IndicationsLiver Cirrhosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A